Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3
Clinical trial NCT02466516 · COMPLETED
Trial details
- NCT number
- NCT02466516
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-08
- Primary completion
- 2016-10-11
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.